
Liofilchem Antibiotic AST Disc Guide
Liofilchem Antibiotic AST Disc Guide
Search only antibiotic names in this guide. All matching names and potencies remain available; choose a suggestion or press Enter to view the results. Select a product name or pack to open its product page.
| Antibiotic / description | Disc code | Potency µg unless units stated |
CLSI1,7 | EUCAST3,4 | Storage temperature | Ref.* | Product / pack |
|---|
No antibiotic names match your search.
Source: Liofilchem Antibiotic Disc IFU, Rev.18 / 20.07.2023, printed pages 15–19 (PDF pages 16–20). Catalogue values and marks are reproduced from the supplied table; the source notes that its product list may be out of date. Product links reflect the current published Kormay catalogue.
Catalogue symbols, packaging and reference notes
Storage temperatures follow the supplied catalogue: items marked ● are stored at −20°C; all other items are shown as −20°C to +8°C.
* Packaging: 5 cartridges of 50 discs (250 discs). Single cartridges of 50 discs use catalogue suffix /1; canisters of 250 discs use suffix /2. Examples from the source: 9045/1 = Vancomycin 30 µg, one cartridge of 50 discs; 9045/2 = Vancomycin 30 µg, canister of 250 discs. The links above show the packs currently published in the store.
Blank cells remain blank where the catalogue provides no potency or mark. The veterinary table does not contain an EUCAST column. Marks reproduce the source and do not indicate stock availability.
- 1: CLSI M100S, 33rd edition, 2023 (clinical list).
- 3, 4: EUCAST breakpoint tables and quality control tables, version 13.2, 2023.
- 7: CLSI VET08, 4th edition, 2018 (veterinary list).
- 9: EUCAST combination disk test guidance for ESBL confirmation, February 2019.
- 10: EUCAST resistance mechanism detection guidelines, version 2.0, July 2017.
The source directs users to current CLSI and EUCAST recommendations for specific organism/agent combinations and notes that testing and reporting agents without interpretive criteria is the chief microbiologist’s responsibility, with infectious disease clinician input.
